Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: 360iResearch | PRODUCT CODE: 1594358

Cover Image

PUBLISHER: 360iResearch | PRODUCT CODE: 1594358

Mouth Ulcers Treatment Market by Drug Class (Analgesics, Antihistamine, Antimicrobial), Formulation (Gels & Ointments, Mouthwash, Sprays), End-User - Global Forecast 2025-2030

PUBLISHED:
PAGES: 193 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF, Excel & 1 Year Online Access (Single User License)
USD 3939
PDF, Excel & 1 Year Online Access (2-5 User License)
USD 4249
PDF, Excel & 1 Year Online Access (Site License)
USD 5759
PDF, Excel & 1 Year Online Access (Enterprise User License)
USD 6969

Add to Cart

The Mouth Ulcers Treatment Market was valued at USD 1.23 billion in 2023, expected to reach USD 1.30 billion in 2024, and is projected to grow at a CAGR of 5.26%, to USD 1.77 billion by 2030.

The scope of the mouth ulcers treatment market encompasses the products and therapies aimed at alleviating the symptoms and promoting healing of mouth ulcers, or aphthous ulcers, which are painful sores that occur in the oral cavity. The necessity for these treatments arises from the prevalence of mouth ulcers, which affect a significant portion of the population due to causes like stress, nutritional deficiencies, and certain health conditions. Applications of mouth ulcer treatments include over-the-counter gels, creams, rinses, and prescribed medications, targeting immediate relief and accelerated healing. End-use segments involve hospitals, dental clinics, and home care settings, reflecting a broad consumer base from professional dental care to self-care solutions. Key growth factors driving the market include increasing awareness about oral health, advancements in pharmaceutical formulations, and the rising demand for quick-relief solutions. Emerging opportunities lie in the development of natural or herbal-based treatments, reflecting growing consumer preference for organic products. Furthermore, increasing urbanization and lifestyle changes are encouraging preventive care focus, presenting opportunities for companies to innovate preventive care solutions. However, market growth is challenged by factors like product efficacy concerns, potential side effects, and pricing pressures in emerging markets. Additionally, the lack of awareness in developing regions acts as a constraint. Innovations are seen in nanotechnology applications for sustained drug release and the use of biotechnology for targeted therapies. Greater integration of artificial intelligence in research for predictive modeling and personalized treatment plans represents a frontier for business growth. Research focused on minimizing side-effects and maximizing drug delivery efficacy is poised to improve treatment outcomes. The market remains competitive with established pharmaceutical companies and new entrants exploring bio-friendly and cost-effective solutions, emphasizing the importance of strategic alliances and continuous innovation to maintain market presence and leverage new opportunities.

KEY MARKET STATISTICS
Base Year [2023] USD 1.23 billion
Estimated Year [2024] USD 1.30 billion
Forecast Year [2030] USD 1.77 billion
CAGR (%) 5.26%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Mouth Ulcers Treatment Market

The Mouth Ulcers Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • High prevalence of mouth ulcers among global population
    • Availability of over-the-counter products for mouth ulcer treatment
    • Growing emphasis on patient-centric care mouth ulcer treatment plans
  • Market Restraints
    • Limited efficacy of existing treatments for mouth ulcers
  • Market Opportunities
    • Introduction of new and more effective mouth ulcer treatments
    • Rising healthcare expenditure and increased focus on oral health
  • Market Challenges
    • Certain side effects associated with mouth ulcers

Porter's Five Forces: A Strategic Tool for Navigating the Mouth Ulcers Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Mouth Ulcers Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Mouth Ulcers Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Mouth Ulcers Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Mouth Ulcers Treatment Market

A detailed market share analysis in the Mouth Ulcers Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Mouth Ulcers Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Mouth Ulcers Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Mouth Ulcers Treatment Market

A strategic analysis of the Mouth Ulcers Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Mouth Ulcers Treatment Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Apotex Inc., Blairex Laboratories Inc, Blistex Inc., Bristol-Myers Squibb Company, Church & Dwight, Inc., Colgate- Palmolive Company, Dr. Reddy's Laboratories Ltd, EPIEN Medical Inc., GlaxoSmithKline PLC, Guilin Sanjin Pharmaceutical Co Ltd, ICPA Health Products Ltd., Intas Pharmaceuticals Ltd., LloydsPharmacy Limited, Meta Tubex Private Limited, Patterson Dental Supply, Inc., Pfizer Inc., Prince Care Pharma Private Limited, Raptakos Brett & Company Limited, Reckitt Benckiser Group PLC, Sinclair Pharma Ltd., STADA Arzneimittel AG, Sun Pharmaceutical Industries Ltd, Sunstar Suisse S.A, and Taro Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Mouth Ulcers Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Drug Class, market is studied across Analgesics, Antihistamine, Antimicrobial, and Corticosteroids.
  • Based on Formulation, market is studied across Gels & Ointments, Mouthwash, and Sprays.
  • Based on End-User, market is studied across Dental Clinics and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-2A0283E25685

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High prevalence of mouth ulcers among global population
      • 5.1.1.2. Availability of over-the-counter products for mouth ulcer treatment
      • 5.1.1.3. Growing emphasis on patient-centric care mouth ulcer treatment plans
    • 5.1.2. Restraints
      • 5.1.2.1. Limited efficacy of existing treatments for mouth ulcers
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of new and more effective mouth ulcer treatments
      • 5.1.3.2. Rising healthcare expenditure and increased focus on oral health
    • 5.1.4. Challenges
      • 5.1.4.1. Certain side effects associated with mouth ulcers
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Mouth Ulcers Treatment Market, by Drug Class

  • 6.1. Introduction
  • 6.2. Analgesics
  • 6.3. Antihistamine
  • 6.4. Antimicrobial
  • 6.5. Corticosteroids

7. Mouth Ulcers Treatment Market, by Formulation

  • 7.1. Introduction
  • 7.2. Gels & Ointments
  • 7.3. Mouthwash
  • 7.4. Sprays

8. Mouth Ulcers Treatment Market, by End-User

  • 8.1. Introduction
  • 8.2. Dental Clinics
  • 8.3. Hospitals

9. Americas Mouth Ulcers Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Mouth Ulcers Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Mouth Ulcers Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Apotex Inc.
  • 3. Blairex Laboratories Inc
  • 4. Blistex Inc.
  • 5. Bristol-Myers Squibb Company
  • 6. Church & Dwight, Inc.
  • 7. Colgate- Palmolive Company
  • 8. Dr. Reddy's Laboratories Ltd
  • 9. EPIEN Medical Inc.
  • 10. GlaxoSmithKline PLC
  • 11. Guilin Sanjin Pharmaceutical Co Ltd
  • 12. ICPA Health Products Ltd.
  • 13. Intas Pharmaceuticals Ltd.
  • 14. LloydsPharmacy Limited
  • 15. Meta Tubex Private Limited
  • 16. Patterson Dental Supply, Inc.
  • 17. Pfizer Inc.
  • 18. Prince Care Pharma Private Limited
  • 19. Raptakos Brett & Company Limited
  • 20. Reckitt Benckiser Group PLC
  • 21. Sinclair Pharma Ltd.
  • 22. STADA Arzneimittel AG
  • 23. Sun Pharmaceutical Industries Ltd
  • 24. Sunstar Suisse S.A
  • 25. Taro Pharmaceutical Industries Ltd.
Product Code: MRR-2A0283E25685

LIST OF FIGURES

  • FIGURE 1. MOUTH ULCERS TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. MOUTH ULCERS TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES MOUTH ULCERS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES MOUTH ULCERS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. MOUTH ULCERS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. MOUTH ULCERS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MOUTH ULCERS TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MOUTH ULCERS TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY ANTIHISTAMINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY ANTIMICROBIAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY GELS & OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY MOUTHWASH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY SPRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES MOUTH ULCERS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. MOUTH ULCERS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. MOUTH ULCERS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!